OptimizeRx

Publicly traded HCP and patient engagement platform whose Dynamic Audience Activation Platform applies AI micro-targeting to real-world data.

OptimizeRx, founded in 2006 and headquartered in Waltham, Massachusetts, is a publicly traded company (Nasdaq: OPRX) providing digital health messaging that reaches clinicians within EHR workflows and patients directly. Its Dynamic Audience Activation Platform (DAAP) applies AI micro-targeting over de-identified real-world data to time brand messages to clinically relevant moments. No public security certification page is documented, so request security documentation during evaluation.

Headquarters
Waltham, United States
Founded
2006
Deployment options
cloud
Website
https://www.optimizerx.com
LinkedIn
https://www.linkedin.com/company/oprx

Categories

AI Use Cases

  • Patient Identification & Segmentation

Vendor Scorecard

50% — Partial coverage. Coverage score — how completely Atlas documents OptimizeRx across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Mid-Size Biotech, Large Pharma, Top 20 Pharma, Commercial

Solution Scope — Documented

Real-World Evidence

Company Viability — Partially documented

Public, Founded 2006

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • Which EHR and point-of-care networks does messaging reach?
  • How is DAAP audience-model performance measured and reported?
  • How is de-identification of the underlying real-world data validated?
  • What compliance review workflow exists for message content?